Evidence map›Paper›PMID 32970072›Full record

ArticleDalton transactions (Cambridge, England : 2003)2020

Revisiting dithiadiaza macrocyclic chelators for copper-64 PET imaging.

Sergey Shuvaev, Elizaveta A Suturina, Nicholas J Rotile, Andrei Astashkin, Christopher J Ziegler, Alana W Ross, Tia L Walker, Peter Caravan, Ian S Taschner

Open access · greenAbstract read
In one paragraph

Article in Dalton transactions (Cambridge, England : 2003), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Is Smaller Better? CuInorganic chemistry · 2023
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Sergey ShuvaevA. A. Martinos Center for Biomedical Imaging and the Institute for Innovation in Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. sshuvaev@mgh.harvard.edu.ORCID http://orcid.org/0000-0001-7903-0648
Elizaveta A SuturinaDepartment of Chemistry, University of Bath, Claverton Down, Bath BA2 7AY, UK. e.suturina@bath.ac.uk.ORCID http://orcid.org/0000-0003-4407-1882
Nicholas J RotileA. A. Martinos Center for Biomedical Imaging and the Institute for Innovation in Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. sshuvaev@mgh.harvard.edu.
Andrei AstashkinDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721, USA.
Christopher J ZieglerDepartment of Chemistry, University of Akron, Akron, OH 44325, USA.ORCID http://orcid.org/0000-0002-0142-5161
Alana W RossA. A. Martinos Center for Biomedical Imaging and the Institute for Innovation in Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. sshuvaev@mgh.harvard.edu.
Tia L WalkerDepartment of Chemistry, Indiana University Northwest, Gary, IN 46408, USA. itaschne@iun.edu.ORCID http://orcid.org/0000-0001-6499-7856
Peter CaravanA. A. Martinos Center for Biomedical Imaging and the Institute for Innovation in Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. sshuvaev@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-3179-6537
Ian S TaschnerDepartment of Chemistry, Indiana University Northwest, Gary, IN 46408, USA. itaschne@iun.edu.ORCID http://orcid.org/0000-0002-4210-9288
Harvard University · USNorthwest University · USUniversity of Akron · USUniversity of Arizona · USUniversity of Bath · GB

Funding

PET Imaging of ThrombusR01HL109448 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D, SOSNOVIK, DAVID E · 2011 to 2025
$9.6M
Optimization of PET probe for imaging lung fibrogenesisR33HL154125 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2020 to 2021
$1.2M
MRI-Compatible PET Insert for Small Bore ScannerS10OD023503 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2017 to 2017
$600k
Electronics Upgrade for 11.7 TS10OD025234 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2018 to 2018
$595k
HPLC-ICP-MS SystemS10OD010650 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2013 to 2013
$371k
NHLBI NIH HHS R01 HL109448NHLBI NIH HHS R33 HL154125NIH HHS S10 OD010650NIH HHS S10 OD023503NIH HHS S10 OD025234
6 · The paper itself

Abstract

Synthesis and characterisation of a dithiadiaza chelator NSNS2A, as well as copper complexes thereof are reported in this paper. Solution structures of copper(i/ii) complexes were calculated using density functional theory (DFT) and validated by both NMR and EPR spectroscopy. DFT calculations revealed a switch in the orientation of tetragonal distortion upon protonation, which might be responsible for poor stability of the Cu(II)NSNS2A complex in aqueous media, whilst the same switch in tetragonal distortion was experimentally observed by changing the solvent. The chelator was radiolabeled with 64Cu and evaluated using PET/MRI in rats. Despite a favorable redox potential to stabilize the cuprous state in vivo, the 64Cu(II)NSNS2A complex showed suboptimal stability compared to its tetraazamacrocyclic analogue, 64Cu(TE2A), with a significant 64Cu uptake in the liver.

Indexed as

AnimalsAza CompoundsAzurinChelating AgentsCoordination ComplexesCopper RadioisotopesDensity Functional TheoryElectrochemical TechniquesKidneyLiverMacrocyclic CompoundsMagnetic Resonance ImagingMaleMolecular ConformationOxidation-ReductionPositron-Emission TomographyAza CompoundsAzurinChelating AgentsCoordination ComplexesCopper-64Copper RadioisotopesMacrocyclic CompoundsRadiopharmaceuticalsSolvents

Identifiers

PMID32970072
PMCPMC7967274
OpenAlexW3087673061

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.